Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in KYTX — Kyverna Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to KYTX Full portfolio

Position in KYTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,364,758
+$1,883,826 QoQ
Shares Held
265,405
+376.3% QoQ
Ownership
0.429%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 120 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KYTX Over Time

Shares Held

Position Value (USD)

Derivatives in KYTX

reported options exposure · as of Mar 31, 2024
CallValue
$0
CallShares
0
PutValue
$7,452
PutShares
300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. KYTX ranks #180 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in KYTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,364,758 265,405
2026-03-31 $480,932 55,728
2025-12-31 $269,863 28,709
2025-09-30 $389,784 64,964
2025-06-30 $103,630 33,756
2025-03-31 $33,438 17,326
2024-12-31 $81,486 21,788
2024-09-30 $75,246 15,388
2024-06-30 $188,992 25,199
2024-03-31 $323,316 13,016
2024-03-31 $7,452 300